These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 25665959)

  • 1. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
    Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
    Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
    J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
    Wichgers Schreur PJ; Oreshkova N; Moormann RJ; Kortekaas J
    J Virol; 2014 Sep; 88(18):10883-93. PubMed ID: 25008937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
    Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
    Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
    Prajeeth CK; Zdora I; Saletti G; Friese J; Gerlach T; Wilken L; Beicht J; Kubinski M; Puff C; Baumgärtner W; Kortekaas J; Wichgers Schreur PJ; Osterhaus ADME; Rimmelzwaan GF
    Emerg Microbes Infect; 2024 Dec; 13(1):2373313. PubMed ID: 38946528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
    Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.
    Lorenzo G; López-Gil E; Ortego J; Brun A
    Vet Res; 2018 Feb; 49(1):21. PubMed ID: 29467018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
    Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Rift Valley fever virus viremia challenge model in sheep and goats.
    Weingartl HM; Miller M; Nfon C; Wilson WC
    Vaccine; 2014 Apr; 32(20):2337-44. PubMed ID: 24631070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
    Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
    Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.